TORONTO, ON / ACCESSWIRE / March 2, 2016 / Profound Medical Corp. (TSX-V: PRN) will host a conference call to discuss the results of the full year 2015, to be held Thursday, March 3, 2016 at 8:30 AM Eastern Time.
To participate in this event, dial 877-407-9210 domestically, or 201-689-8049 internationally, approximately 5 to 10 minutes before the beginning of the call.
You may access the teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID # 13630480. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on April 2, 2016.
About Profound Medical Corp.
Profound Medical is a Canadian medical device company that has developed a unique and minimally invasive treatment to ablate the prostate gland in prostate cancer patients. Profound's novel technology combines real-time MR imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. It provides a highly precise treatment tailored to patient-specific anatomy and pathology. This method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery. The potential of this technology is currently being demonstrated in clinical trials. For more information, visit profoundmedical.com.
SOURCE: Investor Calendar
